Skip to main content
2024 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Anton Rosenbaum

Senior Group Director
AstraZeneca
South San Francisco, California

Anton Rosenbaum is Head of South San Francisco Integrated Bioanalysis at AstraZeneca and member of global BioA LT. Anton has been the Global Lead for all ADC Bioanalysis at AstraZeneca accountable for all aspects of ADC bioanalysis from early preclinical discovery to BLA and LCM conducted by bioanalytical groups at several sites and countries and numerous projects/platform studies. Anton was responsible for establishing Biologics by LC-MS BioA group at AstraZeneca and acting as Test Site Management for South San Francisco, CA site. Anton’s group supports a variety of preclinical and clinical programs focusing on novel therapeutic modalities across the portfolio of diverse therapeutic areas. Anton’s expertise is focused on quantitative bioanalysis, immunogenicity and metabolism of biotherapeutics, novel excipients, identification and quantification of clinically relevant biomarkers and their application to drug development using OMICs approaches. Prior to joining AZ Anton was Senior Scientist at Pfizer-CTI and Postdoctoral Fellow at Genentech. Anton obtained his PhD in Biochemistry and Structural Biology from the Weill Graduate School of Cornell University.

Disclosure information not submitted.

Presentation(s):